Position in VRDN
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$22,901,415
-$71,787,502 QoQ
Shares Held
1,170,829
-61.5% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,580,660,548 across 68 Biotechnology names. VRDN ranks #42 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in VRDN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,901,415 | 1,170,829 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $94,688,917 | 3,042,703 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,558,592 | 1,462,400 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,256,147 | 447,507 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,892,243 | 659,662 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $28,496,358 | 1,486,508 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $63,988,128 | 2,812,665 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,230,082 | 1,631,828 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $64,035,803 | 3,657,099 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $37,684,017 | 1,730,212 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $15,511,884 | 1,011,205 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,260,222 | 1,776,386 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $44,173,659 | 1,736,386 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $35,652,995 | 1,220,575 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,033,993 | 1,220,575 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,244,096 | 971,832 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,312,249 | 1,423,053 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $28,133,757 | 1,423,053 | Shares | Sole | 2022-05-04 | |
| 2021-09-30 | $23,408,350 | 1,423,000 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $14,531,514 | 794,506 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||